AzTrials
AzTrials

ConsultationNCT07680218

Clinical and Diagnostic Profile of Dermatology Consultations in a Tertiary Care University Hospital: A Retrospective Observational Study

An observational study of Consultation and Dermatology, run by Biruni University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: Dermatology consultations requested by non-dermatology departments in hospital settings are common and play a critical role in patient management. These consultations often involve diagnostic challenges and may influence treatment decisions, hospital stay, and clinical outcomes. Read more about this study

Who is it for?
Any age
Conditions the study is for
Consultation, Dermatology
How many people
321 participants
Where
1 siteTurkey (Türkiye)
Study dates
23 Feb 2026to 22 Jun 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: All inpatient and outpatient dermatology consultations requested by non-dermatology departments in a tertiary care university hospital.

Who may be able to join

  • All inpatient and outpatient dermatology consultations requested by non-dermatology departments were included

Who cannot join

  • Incomplete or missing medical records were excluded

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Biruni University Hospital

    Istanbul, Turkey

Other trials in Turkey (Türkiye)

About this study

Background: Dermatology consultations requested by non-dermatology departments in hospital settings are common and play a critical role in patient management. These consultations often involve diagnostic challenges and may influence treatment decisions, hospital stay, and clinical outcomes.

Objective: To evaluate the clinical and diagnostic characteristics of dermatology consultations in a tertiary care university hospital over a two and a half years period.

Read the detailed description

This retrospective observational study was conducted at the dermatology department of a university hospital, a tertiary care center, between January 2024 and June 2026.

All inpatient and outpatient dermatology consultations requested by non-dermatology departments were included. Incomplete or missing medical records were excluded. Data were extracted from electronic medical records using a standardized data collection form. The following variables were recorded: Demographic characteristics (age, sex), requesting department, dermatologic symptoms and presenting complaints, final dermatologic diagnosis, diagnostic procedures (e.g., biopsy, microbiological tests), treatment recommendations and follow-up plans.

Frequency and distribution of dermatologic diagnoses, distribution of consultation reasons, rate of histopathological confirmation, diagnostic concordance between referring physicians and dermatologists were examined.

Statistical analyses were performed using appropriate software. Descriptive statistics (mean, median, percentages) were used to summarize the data. Categorical variables were compared using the chi-square test. A p-value < 0.05 was considered statistically significant.

Diagnoses were grouped into six major categories: Infectious dermatoses, inflammatory dermatoses, drug-related skin reactions, autoimmune/bullous diseases, tumors and precancerous lesions, other dermatologic conditions.

Keywords
dermatology consultation, skin diseases, tertiary care hospital
Medical subject headings
Skin Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07680218
Study groupRoleWhat they receive
consultationsAll inpatient and outpatient dermatology consultations requested by non-dermatology departments were included

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. diagnoses groups

    Diagnoses were grouped into six major categories: Infectious dermatoses, inflammatory dermatoses, drug-related skin reactions, autoimmune/bullous diseases, tumors and precancerous lesions, other dermatologic conditions.

    Measured: 2 and a half year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jul 2026
  2. Study start23 Feb 2026
  3. Primary completion15 Jun 2026
  4. Study completion22 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
321 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07680218
Sponsor's protocol ID
BIAEK/18-08
Status last verified
Jun 2026
First submitted
23 Jun 2026
Last updated
2 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Consultation and Dermatology, run by Biruni University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

diagnoses groups (time frame: 2 and a half year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in